A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : FVIII

Search Conditions:
Search Keyword : FVIII
Search Method : Exact match.
Research Area:

Results:  
Abbreviation: FVIII
Appearance Frequency: 2613 time(s)
Long forms: 59

Display Settings:
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
factor VIII
(2268 times)
Hematology
(1348 times)
vWF (532 times)
VWD (184 times)
HA (149 times)
1976 Factor VIII synthesis: hepatic and renal allografts in swine with von Willebrand's disease.
factor VIII coagulant activity
(60 times)
Hematology
(44 times)
vWF (33 times)
VWD (15 times)
APTT (3 times)
1981 Newborn factor VIII complex: elevated activities in term infants and alterations in electrophoretic mobility related to illness and activated coagulation.
anti-factor VIII
(55 times)
Hematology
(32 times)
vWF (9 times)
HA (3 times)
rFVIIIFc (3 times)
1988 Localization of the binding regions of a murine monoclonal anti-factor VIII antibody and a human anti-factor VIII alloantibody, both of which inhibit factor VIII procoagulant activity, to amino acid residues threonine351-serine365 of the factor VIII heavy chain.
factor VIII activity
(44 times)
Hematology
(25 times)
vWF (20 times)
VWD (9 times)
APTT (8 times)
1977 Inherited platelet abnormalities associated with low factor VIII activity in the same family.
FVIII activity
(30 times)
Hematology
(23 times)
vWF (9 times)
APTT (6 times)
HA (6 times)
2002 A Tyr346-->Cys substitution in the interdomain acidic region a1 of factor VIII in an individual with factor VIII:C assay discrepancy.
FVIII coagulant activity
(21 times)
Hematology
(17 times)
vWF (15 times)
VWD (3 times)
FIX (2 times)
1987 The effects of desmopressin on plasma factor VIII/von Willebrand factor activity in dogs with von Willebrand's disease.
factor VIII coagulant
(17 times)
Hematology
(6 times)
vWF (13 times)
VWD (9 times)
APTT (2 times)
1979 Acquired von Willebrand disease associated with an inhibitor to factor VIII antigen and gastrointestinal telangiectasia.
factor VIII-related antigen
(17 times)
Pathology
(8 times)
EMA (2 times)
LCA (2 times)
OS (2 times)
1981 Newborn factor VIII complex: elevated activities in term infants and alterations in electrophoretic mobility related to illness and activated coagulation.
factor VIII antigen
(12 times)
Hematology
(7 times)
AvWF (1 time)
BTCs (1 time)
CVD (1 time)
1985 Distribution of factor VIII mRNA and antigen in human liver and other tissues.
10  FVIII antigen
(9 times)
Hematology
(8 times)
VWF (7 times)
BDD (1 time)
CRM (1 time)
1988 Fibrinolytic and haemostatic responses to desamino-D-arginine vasopressin (DDAVP) administered by intravenous and subcutaneous routes in healthy subjects.
11  factor VIII clotting activity
(7 times)
Veterinary Medicine
(2 times)
APTT (1 time)
BP (1 time)
CBT (1 time)
1998 Type III von Willebrand's disease in Dutch kooiker dogs.
12  factor VIII concentrates
(6 times)
Hematology
(6 times)
AHC (1 time)
AIDS (1 time)
CI (1 time)
1986 Inactivation of the AIDS-causing retrovirus and other human viruses in antihemophilic plasma protein preparations by pasteurization.
13  factor VIII protein
(5 times)
Hematology
(5 times)
BDD (1 time)
FL (1 time)
HA (1 time)
2001 Viral safety of a pasteurized, monoclonal antibody-purified factor VIII concentrate in previously untreated haemophilia A patients.
14  FVIII clotting activity
(5 times)
Hematology
(5 times)
pd (2 times)
PK (2 times)
vWF (2 times)
1988 Effect of delayed blood processing on the yield of factor VIII in cryoprecipitate and factor VIII concentrate.
15  factor VIII coagulant protein
(4 times)
Hematology
(2 times)
rhFVIIa (1 time)
1984 A moderately severe expression of classical hemophilia in a family of german shepherd dogs.
16  factor VIII gene
(4 times)
Hematology
(3 times)
HA (4 times)
B2M (1 time)
DHPLC (1 time)
2003 Analysis of 18 novel mutations in the factor VIII gene.
17  factor VIII (FVIII) coagulant activity
(3 times)
Hematology
(3 times)
vWF (5 times)
VWD (3 times)
CI (1 time)
1992 Clinical and biological evaluation in von Willebrand's disease of a von Willebrand factor concentrate with low factor VIII activity.
18  factor VIII levels
(2 times)
Hematology
(1 time)
CI (1 time)
HR (1 time)
ISS (1 time)
2010 High incidence of arterial thrombosis in young patients treated for multiple myeloma: results of a prospective cohort study.
19  FVIII coagulation
(2 times)
Hematology
(1 time)
AIS (1 time)
AMI (1 time)
BDD (1 time)
2002 Activation profiles of factor VIII in concentrates reflect one-stage/chromogenic potency discrepancies.
20  FVIII deficiency
(2 times)
Hematology
(2 times)
APC (1 time)
HA (1 time)
PCR (1 time)
2006 Female hemophilia A heterozygous for a de novo frameshift and a novel missense mutation of factor VIII.
21  VWF-factor VIII
(2 times)
Hematology
(2 times)
vWF (2 times)
FFP (1 time)
HMW (1 time)
2002 Molecular genetics of type 2 von Willebrand disease.
22  factor activities
(1 time)
Hematology
(1 time)
--- 2004 A 6-year follow-up of dosing, coagulation factor levels and bleedings in relation to joint status in the prophylactic treatment of haemophilia.
23  factor VIII (FVIII) activity
(1 time)
Hematology
(1 time)
VWF (2 times)
HA (1 time)
VWD (1 time)
2014 Similarity in joint and mucous bleeding syndromes in type 2N von Willebrand disease and severe hemophilia A coexisting with type 1 von Willebrand disease in two Chinese pedigrees.
24  factor VIII activity assay
(1 time)
Hematology
(1 time)
--- 1997 High prevalence of elevated factor VIII levels in patients referred for thrombophilia screening: role of increased synthesis and relationship to the acute phase reaction.
25  factor VIII activity in plasma
(1 time)
Medicine
(1 time)
--- 2018 Assessment of Relative Bioavailability of Moroctocog Alfa and Moroctocog Alfa (AF-CC) in Subjects With Severe Hemophilia A.
26  factor VIII clot
(1 time)
Chemistry, Clinical
(1 time)
APTT (1 time)
INR (1 time)
MoM (1 time)
2018 Within-subject biological variation of activated partial thromboplastin time, prothrombin time, fibrinogen, factor VIII and von Willebrand factor in pregnant women.
27  Factor VIII clotting assay
(1 time)
Hematology
(1 time)
--- 2006 Accuracy of FVIII: C assay by one-stage method can be improved using hemophilic plasma as diluent.
28  factor VIII components
(1 time)
Vascular Diseases
(1 time)
--- 1981 Studies on the haemostatic system in peripheral arterial disease. 2. Variations in factor VIII components (FVIII:C ; FVIIIR:Ag ; FVIII:WF) before and after venous occlusion.
29  factor VIII deficiency
(1 time)
Hematology
(1 time)
vWd (1 time)
1985 A study of cell mediated and humoral immunity in haemophilia and related disorders.
30  factor VIII ristocetin cofactor activity
(1 time)
Hematology
(1 time)
DIC (1 time)
1981 Newborn factor VIII complex: elevated activities in term infants and alterations in electrophoretic mobility related to illness and activated coagulation.
31  factor VIII, IX, XI, XII activity
(1 time)
Genetics, Medical
(1 time)
APTT (1 time)
ELISA (1 time)
FIB (1 time)
2018 [Phenotypic and genetic analysis of two pedigrees affected with hereditary coagulation FXII deficiency].
32  Factor VIII-associated antigen
(1 time)
Neurosurgery
(1 time)
GKS (1 time)
2002 Observations of intracranial neoplasms treated with gamma knife radiosurgery.
33  factor VIII:von Willebrand Factor
(1 time)
Hematology
(1 time)
HT (1 time)
1999 [No ELISA detectable alterations in immunogenicity following dry-hear treatment (72 hours at 80 degrees C) of FANHDI].
34  factors VIII and IX activities
(1 time)
Clinical Laboratory Techniques
(1 time)
--- 2018 Effects of Freeze-Thaw Times on Screening Coagulation Tests and Factors VIII and IX Activities in Citrate-Anticoagulated Plasma at -20C and -80C.
35  factors VIII, IX, XI, XII
(1 time)
Chemistry, Clinical
(1 time)
APTT (1 time)
LAC (1 time)
LAC-SR (1 time)
2009 Age-associated developmental changes in the activated partial thromboplastin time (APTT) and causes of prolonged APTT values in healthy Chinese children.
36  factor VIII-deficient plasma
(1 time)
Hematology
(1 time)
APC (1 time)
2011 Activated protein C inhibitor for correction of thrombin generation in hemophilia A blood and plasma1.
37  fibrinolytic parameters in these patients.Factor VIII clotting activity
(1 time)
Physiology
(1 time)
BD (1 time)
MiAU (1 time)
MjAU (1 time)
2011 Anticoagulant and Fibrinolytic Disorders in Patients with Behcet's Disease and Recurrent Aphthous Ulcer.
38  Fuji VIII
(1 time)
Dentistry
(1 time)
FII (1 time)
FIX (1 time)
FT (1 time)
2008 Fluoride content and recharge ability of five glassionomer dental materials.
39  FVIII (rFVIII) activity
(1 time)
Hematology
(1 time)
rFVIII (1 time)
2013 Practical and cost-effective measurement of B-domain deleted and full-length recombinant FVIII in the routine haemostasis laboratory.
40  FVIII activity level
(1 time)
Pathology
(1 time)
CWA (1 time)
TGT (1 time)
2017 [Development of Comprehensive Coagulation Assays Reflecting the Clinical Phenotype].
41  FVIII assay
(1 time)
Hematology
(1 time)
MHA (1 time)
TG (1 time)
2014 Diagnosis and management challenges in patients with mild haemophilia A and discrepant FVIII measurements.
42  FVIII clotting
(1 time)
Biochemistry
(1 time)
SEC (1 time)
1996 Characterization of aggregates of recombinant human factor VIII by size-exclusion chromatography and immunoassay.
43  FVIII coagulant
(1 time)
Hematology
(1 time)
RANKL (1 time)
vWF (1 time)
2019 Factor VIII: Long-established role in haemophilia A and emerging evidence beyond haemostasis.
44  FVIII deficiency was classified as mild
(1 time)
Veterinary Medicine
(1 time)
--- 2014 Clinical outcome after diagnosis of hemophilia A in dogs.
45  FVIII Delta B
(1 time)
Cell Biology
(1 time)
EGFP (1 time)
HSC (1 time)
PKC (1 time)
2002 Generation and characterization of human hematopoietic cell lines expressing factor VIII.
46  FVIII inhibitors
(1 time)
Hematology
(1 time)
HA (1 time)
IT (1 time)
IU (1 time)
2001 Immune tolerance in hemophilia with factor VIII inhibitors: predictors of success.
47  FVIII levels
(1 time)
Medicine
(1 time)
PK (1 time)
2019 Desmopressin treatment combined with clotting factor VIII concentrates in patients with non-severe haemophilia A: protocol for a multicentre single-armed trial, the DAVID study.
48  FVIII levels were determined by one-stage clotting
(1 time)
Vascular Diseases
(1 time)
CAT (1 time)
TG (1 time)
TGT (1 time)
2012 Persistent high factor VIII activity leading to increased thrombin generation - a prospective cohort study.
49  FVIII one-stage clotting value
(1 time)
Hematology
(1 time)
CAT (1 time)
ETP (1 time)
2010 Thrombin generation in haemophilia A patients with mutations causing factor VIII assay discrepancy.
50  FVIII protein content
(1 time)
Hematology
(1 time)
ELISA (1 time)
pd (1 time)
vWF (1 time)
2004 Relationships between factor VIII:Ag and factor VIII in recombinant and plasma-derived factor VIII concentrates.
51  FVIII-Ab
(1 time)
Hematology
(1 time)
HM (1 time)
VWD (1 time)
1997 Alloantibody from a patient with severe von Willebrand disease inhibits von Willebrand factor-FVIII interaction.
52  FVIII-LFB, commercialized as Facteur VIII-LFB
(1 time)
Hematology
(1 time)
vWF (1 time)
2007 A solvent/detergent-treated and 15-nm filtered factor VIII: a new safety standard for plasma-derived coagulation factor concentrates.
53  FVIII-ristocetin co-factor activity
(1 time)
Veterinary Medicine
(1 time)
VWD (1 time)
1987 The effects of desmopressin on plasma factor VIII/von Willebrand factor activity in dogs with von Willebrand's disease.
54  FVIII-vWF; one of these two completely inhibited the procoagulant activity
(1 time)
Hematology
(1 time)
FVIII-vWF (1 time)
1984 Characterization of 25 monoclonal antibodies to factor VIII-von Willebrand factor: relationship between ristocetin-induced platelet aggregation and platelet adherence to subendothelium.
55  FVIII/W ratio
(1 time)
Hematology
(1 time)
AHA (1 time)
APTT (1 time)
vWF (1 time)
2019 The factor VIII:C/VWF:Ag ratio as a useful tool to predict relapse in patients with acquired haemophilia A: A retrospective cohort study.
56  FVIII: C were increased markedly in the supernatant of HUVEC
(1 time)
Hematology
(1 time)
BDDhF VIII cDNA (1 time)
HUVEC (1 time)
2007 [Effect of L-arginine on human coagulant factor VIII gene expression].
57  FVIII:c
(1 time)
Cell Biology
(1 time)
MSC (1 time)
2013 Mesenchymal stem cells contribute to endogenous FVIII:c production.
58  FVIII:C of the mutations was determined using two one-stage assays
(1 time)
Hematology
(1 time)
HA (1 time)
TGT (1 time)
2019 In silico and in vitro evaluation of the impact of mutations in non-severe haemophilia A patients on assay discrepancies.
59  FVIII:C results, whereby the one-stage clotting assay
(1 time)
Hematology
(1 time)
--- 2013 Diagnostic testing for mild hemophilia a in patients with discrepant one-stage, two-stage, and chromogenic factor VIII:C assays.